H-AALLNKLYA-OH

Ref. 3D-PP44937

Información del producto

• Nombre: H-AALLNKLYA-OH
• Sinónimos: NH2-Ala-Ala-Leu-Leu-Asn-Lys-Leu-Tyr-Ala-OH

Descripción

Peptide H-AALLNKLYA-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-AALLNKLYA-OH include the following: Identification of a glioma antigen, GARC-1, using cytotoxic T lymphocytes induced by HSV cancer vaccine Y Iizuka, H Kojima, T Kobata, T Kawase - journal of cancer, 2006 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.21432 Endogenous neoantigen-specific CD8 T cells identified in two glioblastoma models using a cancer immunogenomics approach TM Johanns, JP Ward, CA Miller , C Wilson - Cancer immunology , 2016 - AACRhttps://aacrjournals.org/cancerimmunolres/article-abstract/4/12/1007/468147 Effective immunotherapy against murine gliomas using type 1 polarizing dendritic cells-significant roles of CXCL10 M Fujita , X Zhu, R Ueda, K Sasaki , G Kohanbash - Cancer research, 2009 - AACRhttps://aacrjournals.org/cancerres/article-abstract/69/4/1587/552871 rWTC-MBTA Vaccine Induces Potent Adaptive Immune Responses Against Glioblastomas via Dynamic Activation of Dendritic Cells H Wang, R Medina, J Ye , Y Zhang - Advanced , 2024 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/advs.202308280 Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas G Kohanbash , DA Carrera, S Shrivastav - The Journal of , 2017 - Am Soc Clin Investighttps://www.jci.org/articles/view/90644 Immunotherapy for murine glioma B Tang - 2020 - ideals.illinois.eduhttps://www.ideals.illinois.edu/items/115740

• Marca: Biosynth